Compare DASH & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DASH | BSX |
|---|---|---|
| Founded | 2013 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.8B | 68.0B |
| IPO Year | 2020 | 2010 |
| Metric | DASH | BSX |
|---|---|---|
| Price | $152.76 | $41.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 41 | 31 |
| Target Price | ★ $250.39 | $49.60 |
| AVG Volume (30 Days) | 5.7M | ★ 17.8M |
| Earning Date | 10-29-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 634.48 | 55.20 |
| EPS | ★ 1.93 | 1.92 |
| Revenue | ★ $13,717,000,000.00 | $9,076,000,000.00 |
| Revenue This Year | $30.84 | $4.46 |
| Revenue Next Year | $21.15 | N/A |
| P/E Ratio | $81.42 | ★ $22.39 |
| Revenue Growth | ★ 27.93 | 12.49 |
| 52 Week Low | $143.30 | $39.57 |
| 52 Week High | $239.00 | $101.91 |
| Indicator | DASH | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 31.75 | 42.76 |
| Support Level | $145.41 | $39.57 |
| Resistance Level | $193.12 | $46.31 |
| Average True Range (ATR) | 8.34 | 1.49 |
| MACD | -2.17 | -0.17 |
| Stochastic Oscillator | 2.14 | 1.57 |
DoorDash is an online delivery demand aggregator. Consumers can use its app to order food on demand for delivery or in-store pickup from participating merchants. DoorDash creates a marketplace that lets merchants build an online presence, market their offerings, and meet demand through delivery. The firm provides similar services to non-restaurant businesses, such as grocery, retail, and pet supplies. DoorDash is also rolling out emerging technologies, such as drone delivery, to continually innovate and deliver the best possible service to both supply-side and demand-side participants in its marketplace. The acquisition of Instacart, announced in October 2026, will deepen DoorDash's presence in grocery and local commerce delivery.
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.